Discovery Sciences | for Life Sciences
We describe Sensyne Health’s role as a “docking station” between the providers of data and those who need it to guide medical innovation, and we are proud to provide this connection ethically and efficiently while protecting public trust in how their data is used.
Through our NHS partnerships, we have access to large quantities of rich, anonymised patient data.  This includes information on prescriptions, diagnoses, imaging, pathology and outcomes.  When combined with our proprietary machine learning methods, we can provide actionable insights for the life sciences industry.
Drug development stages diagram
Sensyne are progressing AI pharmacologic discovery programmes in four therapeutic areas:
Lung disease

Autoimmune disease

Neurodegenerative disease

Neurodegenerative disease

cardiovascular disease

Cardiovascular disease  

Immunological diseases and cancer

Immunological disease and cancer

How we work

Undertake [JC1] paid-for research for pharmaceutical companies
Undertake paid-for research for pharmaceutical companies
eCRO services in clinical trial design & analysis of trial results
Clinical trials support and analysis
Real world outcomes for marketed medicines
Real world outcomes for marketed medicines
Take an economic interest in the pharmaceutical product
Take an economic interest in the pharmaceutical product

Partner with us

Like to hear more about how we partner with Life Sciences industry and understand how we could partner with you?

Contact us